...
首页> 外文期刊>Microscopy research and technique >Cellular uptake pathway and drug release characteristics of drug-encapsulated glycol chitosan nanoparticles in live cells
【24h】

Cellular uptake pathway and drug release characteristics of drug-encapsulated glycol chitosan nanoparticles in live cells

机译:药物包裹的乙二醇壳聚糖纳米粒在活细胞中的细胞摄取途径和释药特性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Herein, we evaluated the cellular uptake pathways of hydrophobically modified glycol chitosan (HGC) nanoparticles as nano-sized drug carriers using cellular imaging technology. The endocytic pathway of nanocarriers for intracellular drug delivery is of great interest for the design of high efficacy delivery carriers for therapeutic agents. To evaluate the cellular uptake pathways of HGC nanoparticles, HGC was chemically labeled with near infrared (NIR) fluorescence dye, Cy5.5, to visualize the nanoparticle under confocal laser scanning microscopy. The internalization pathways of HGC nanoparticles were evaluated after treatment of specific endocytosis inhibitors. Importantly, HCG nanoparticles showed different cellular uptake efficiency and intracellular fate in cytoplasm according to the internalization pathways. Furthermore, drug distribution also evaluated according to the endocytic pathways after treatment of drug encapsulated HGC nanoparticles. As a model drug, fluorescent photosensitizer, Ce6, was encapsulated into HGC (Ce6-HGC) nanoparticles and the distribution of Ce6 in cytoplasm was evaluated using confocal laser scanning microscopy. The intracellular drug distribution showed different manner through specific endocytic pathways. The cellular imaging technology is highly useful for evaluation of endocytosis pathways and intracellular fate of drug delivery carrier which are closely related to drug distribution and therapeutic efficacy.
机译:本文中,我们使用细胞成像技术评估了疏水改性的乙二醇壳聚糖(HGC)纳米颗粒作为纳米级药物载体的细胞摄取途径。用于细胞内药物递送的纳米载体的胞吞途径对于设计用于治疗剂的高效递送载体非常感兴趣。为了评估HGC纳米颗粒的细胞摄取途径,将HGC用近红外(NIR)荧光染料Cy5.5化学标记,以在共聚焦激光扫描显微镜下观察纳米颗粒。在治疗特定的内吞抑制剂后,评估了HGC纳米颗粒的内在途径。重要的是,根据内在途径,HCG纳米颗粒在细胞质中显示出不同的细胞吸收效率和细胞内命运。此外,在治疗药物包裹的HGC纳米颗粒后,还根据胞吞途径评估了药物分布。作为模型药物,荧光光敏剂Ce6被封装到HGC(Ce6-HGC)纳米颗粒中,并使用共聚焦激光扫描显微镜评估Ce6在细胞质中的分布。通过特定的内吞途径,细胞内药物分布表现出不同的方式。细胞成像技术对于评估与药物分布和治疗效果密切相关的内吞途径和药物输送载体的细胞内命运非常有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号